Modulation of Pituitary Somatostatin Receptor Subtype (sst1-5) mRNA Levels by Growth Hormone (GH)-Releasing Hormone in Purified Somatotropes |
Park, Seung-Joon
(Department of Pharmacology, Kyunghee University School of Medicine)
Park, Hee-Soon (Department of Pharmacology, Kyunghee University School of Medicine) Lee, Mi-Na (Department of Pharmacology, Kyunghee University School of Medicine) Sohn, Sook-Jin (Department of Pharmacology, Kyunghee University School of Medicine) Kim, Eun-Hee (Department of Pharmacology, Kyunghee University School of Medicine) Jung, Jee-Chang (Department of Pharmacology, Kyunghee University School of Medicine) Frohman, Lawrence A. (Department of Medicine, Section of Endocrinology and Metabolism, University of Illinois at Chicago) Kineman, Rhonda D. (Department of Medicine, Section of Endocrinology and Metabolism, University of Illinois at Chicago) |
1 | Lopes MBS, Gaylinn BD, Thorner MO, Stoler MH. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am J Pathol 150: 1885-1891, 1997 |
2 | Mezey E, Hunyady B, Mitra S, Hayes E, Liu Q, Schaeffer J, Schonbrunn A. Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary. Endocrinology 139: 414-419, 1998 DOI ScienceOn |
3 | Morel G, Gallego R, Boulanger L, Pintos E, Garcia-Caballero T, Gaudreau P. Restricted presence of the growth hormonereleasing hormone receptor to somatotropes in rat and human pituitaries. Neuroendocrinology 70: 128-136, 1999 DOI ScienceOn |
4 | Oka H, Kameya T, Sato Y, Naritaka H, Kawano N. Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization. J Neurooncol 41: 197-204, 1999 DOI ScienceOn |
5 | Rohrer SP, Hayes E, Berk SC, Hutchins SM, Shen D-M, Xiong Y, Parma R, Foor P, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WW, Pasternak A, Yang L, Patchett A, Smith RG, Chapman KT, Schaeffer JM. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282: 737-740, 1998 DOI PUBMED ScienceOn |
6 | Wynick D, Venetikou MS, Critchley R, Burrin JM, Bloom SR. Flow cytometric analysis of functional anterior pituitary cells from female rats. J Endocrinol 126: 261-268, 1990b DOI ScienceOn |
7 | Kineman RD, Aleppo G, Frohman LA. The tyrosine hydroxy lase-human growth hormone (GH) transgenic mouse as a model of hypothalamic GH deficiency: growth retardation is the result of a selective reduction in somatotrope numbers despite normal somatotrope function. Endocrinology 137: 4630-4636, 1996 DOI PUBMED |
8 | Panetta R, Patel YC. Expression of mRNA for all 5 human somatostatin receptor (hSSTR1-5) in pituitary tumors. Life Sci 56: 333-342, 1995 DOI PUBMED ScienceOn |
9 | Kumar U, Laird D, Srikant CB, Escher E, Patel YC. Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotropes: quantitative analysis by double-label immunoflourescence confocal microscopy. Endocrinology 138: 4473-4476, 1997 DOI PUBMED ScienceOn |
10 | Greenman Y, Melmed S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 79: 724-729, 1994b DOI ScienceOn |
11 | Greenman Y, Melmed S. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab 78: 398-403, 1994a DOI ScienceOn |
12 | Smith RG, Van Der Ploeg HT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18: 621-645, 1997 DOI ScienceOn |
13 | Reisine T. Somatostatin. Cell Mol Neurobiol 15: 597-614, 1995 DOI PUBMED ScienceOn |
14 | Aleppo G, Moskal SFI, DeGrandis PA, Kineman RD, Frohman LA. Homologous down-regulation of growth hormone-releasing hormone receptor mRNA levels. Endocrinology 138: 1058-1065, 1997 DOI ScienceOn |
15 | Wynick D, Critchley R, Venetikou MS, Burrin JM, Bloom SR. Purification of functional lactotrophs and somatotrophs from female rats using fluorescence-activated cell sorting. J Endocrinol 126: 269-274, 1990a DOI ScienceOn |
16 | Day R, Dong W, Panetta R, Kracier J, Greenwood MT, Patel YC. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 136: 5232-5235, 1995 DOI ScienceOn |
17 | Park S, Kamegai J, Johnson TA, Frohman LA, Kineman RD. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis. Endocrinology 141: 3556-3530, 2000 DOI PUBMED ScienceOn |
18 | Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Margan B, Coy DH, Culler MD, Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures. J Clin Invest 99: 789-798, 1997a DOI ScienceOn |
19 | O'Carroll AM, Krempels K. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endcorinology 136: 5224-5227, 1995 DOI ScienceOn |
20 | Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S. Somatostatin receptor (SSTR) subtype selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas: novel potential therapy for functioning pituitary tumors. J Clin Invest 100: 2386-2392, 1997b DOI ScienceOn |
21 | Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 20: 157-198, 1999 DOI PUBMED ScienceOn |